JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$3.58B |
| 2 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$2.7B |
| 3 |
Apple
AAPL
|
+$1.71B |
| 4 |
Schwab Short-Term US Treasury ETF
SCHO
|
+$1.57B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.51B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.51B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$920M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$817M |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$794M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.23% |
| 2 | Technology | 15.68% |
| 3 | Financials | 11.13% |
| 4 | Consumer Discretionary | 9.78% |
| 5 | Healthcare | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
KDMN
4851
DELISTED
Kadmon Holdings, Inc.
KDMN
| $291K | ﹤0.01% |
74,918
+9,982
| +15% | +$38.7K |
2018 Q2
12 quarters
|
|
4852
Anika Therapeutics
ANIK
$259M
| $289K | ﹤0.01% |
6,666
+339
| +5% | +$14.4K |
2015 Q4
22 quarters
|
|
4853
Grupo Aeroportuario Centro Norte
OMAB
$4.55B
| $288K | ﹤0.01% |
5,517
-5,057
| -48% | -$262K |
2016 Q3
19 quarters
|
|
|
GNOG
4854
DELISTED
Golden Nugget Online Gaming, Inc. Class A Common Stock
GNOG
| $288K | ﹤0.01% |
22,606
-38,539
| -63% | -$522K |
2021 Q1
1 quarter
|
|
4855
iShares CMBS ETF
CMBS
$458M
| $286K | ﹤0.01% |
5,263
-79
| -1% | -$4.29K |
2020 Q4
2 quarters
|
|
4856
Gran Tierra Energy
GTE
$354M
| $286K | ﹤0.01% |
38,586
+1,389
| +4% | +$9.47K |
2017 Q2
16 quarters
|
|
4857
Legacy Housing
LEGH
$694M
| $286K | ﹤0.01% |
16,952
-10,686
| -39% | -$198K |
2019 Q1
9 quarters
|
|
4858
Harmony Biosciences
HRMY
$2.3B
| $285K | ﹤0.01% |
10,137
-6,985
| -41% | -$210K |
2020 Q3
3 quarters
|
|
4859
Valaris
VAL
$5.52B
| $285K | ﹤0.01% |
+9,877
| New | +$248K |
2021 Q2
0 quarters
|
|
|
ASXC
4860
DELISTED
Asensus Surgical, Inc.
ASXC
| $285K | ﹤0.01% |
+89,833
| New | +$225K |
2021 Q2
0 quarters
|
|
|
PHAS
4861
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
| $285K | ﹤0.01% |
76,606
+5,732
| +8% | +$19.1K |
2019 Q2
8 quarters
|
|
|
BLDP
4862
CALL
Ballard Power Systems
BLDP
$709M
| $284K | ﹤0.01% |
15,700
| – | – |
2021 Q1
1 quarter
|
|
|
INZY
4863
DELISTED
Inozyme Pharma
INZY
| $284K | ﹤0.01% |
16,659
-4,665
| -22% | -$81.2K |
2020 Q3
3 quarters
|
|
|
EVBN
4864
DELISTED
Evans Bancorp Inc
EVBN
| $284K | ﹤0.01% |
7,654
-20,639
| -73% | -$753K |
2017 Q4
14 quarters
|
|
4865
Fortress Biotech
FBIO
$69M
| $283K | ﹤0.01% |
5,266
-5,635
| -52% | -$340K |
2019 Q3
7 quarters
|
|
|
LITS
4866
Lite Strategy Inc
LITS
$42M
| $283K | ﹤0.01% |
4,944
+2,685
| +119% | +$172K |
2018 Q2
12 quarters
|
|
4867
HF Foods Group
HFFG
$92.3M
| $282K | ﹤0.01% |
53,261
-65,728
| -55% | -$409K |
2018 Q4
10 quarters
|
|
4868
Exagen
XGN
$191M
| $282K | ﹤0.01% |
18,843
+4,547
| +32% | +$69.7K |
2019 Q4
6 quarters
|
|
4869
Ardelyx
ARDX
$873M
| $281K | ﹤0.01% |
37,062
+9,183
| +33% | +$67.9K |
2017 Q3
15 quarters
|
|
4870
EyePoint Inc
EYPT
$278M
| $281K | ﹤0.01% |
31,218
+31,098
| +25,915% | +$299K |
2019 Q2
8 quarters
|
|
4871
Grupo Aeroportuario del Pacifico
PAC
$11.7B
| $281K | ﹤0.01% |
2,625
-667
| -20% | -$72.5K |
2015 Q2
24 quarters
|
|
4872
ARS Pharmaceuticals
SPRY
$410M
| $281K | ﹤0.01% |
9,095
-19,255
| -68% | -$617K |
2021 Q1
1 quarter
|
|
|
OTRA
4873
DELISTED
OTR Acquisition Corp. Class A Common Stock
OTRA
| $281K | ﹤0.01% |
+28,000
| New | +$281K |
2021 Q2
0 quarters
|
|
4874
WisdomTree US AI Enhanced Value Fund
AIVL
$406M
| $280K | ﹤0.01% |
2,880
-200
| -6% | -$19.6K |
2014 Q4
26 quarters
|
|
4875
Foghorn Therapeutics
FHTX
$173M
| $280K | ﹤0.01% |
26,235
+6,224
| +31% | +$67.8K |
2020 Q4
2 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2021 Portfolio in Review
As of Q2 2021, JP Morgan Chase held 6,872 positions worth $838B, up 12% from $749B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase deployed $31.1B of net new capital in Q2 2021, opening 693 new positions and adding to 2,351 existing holdings. Its largest new stake was DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share: 25,313,889 shares worth $358M.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, up from 26% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was iShares 20+ Year Treasury Bond ETF, an estimated $1.51B trimmed.
- JP Morgan Chase's largest Q2 2021 buy was DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share: 25,313,889 shares worth $358M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q2 2021, an estimated $3.58B increase.
- JP Morgan Chase's biggest Q2 2021 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $1.51B.
- JP Morgan Chase fully exited INPHI CORPORATION in Q2 2021, selling an estimated $333M.
- JP Morgan Chase's ten largest holdings make up 16% of its $838B portfolio in Q2 2021.
- JP Morgan Chase opened 693 new positions and closed 449 in Q2 2021.
- JP Morgan Chase's portfolio value rose 12% quarter-over-quarter to $838B.
Based on JP Morgan Chase's 13F filing for Q2 2021, filed 12 Aug 2021.